Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines
NCT ID: NCT03164590
Last Updated: 2020-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2017-06-01
2018-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain
NCT02455609
Topical Ketamine Versus Caudal Ketamine for Postoperative Analgesia in Children Undergoing Inguinal Herniotomy
NCT02462174
Subcutaneous Wound Infiltration of Ketamine or Bupivacaine Pain Perception After Cesarean Section
NCT02515422
Lidocaine and Ketamine in Abdominal Surgery
NCT00721110
Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy
NCT03393572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ketamine
Ketamine
patients receive local anesthetic wound infiltration with 1 mg /kg ketamine
dexmedetomidine
dexmedetomidine
patients receive local anesthetic wound infiltration with 1µg/kg dexmedetomidine
bupivacaine
Ketamine
patients receive local anesthetic wound infiltration with 1 mg /kg ketamine
dexmedetomidine
patients receive local anesthetic wound infiltration with 1µg/kg dexmedetomidine
bupivacaine
patients receive local anesthetic wound infiltration with bupivacaine 0.5 % diluted in 20 ml saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine
patients receive local anesthetic wound infiltration with 1 mg /kg ketamine
dexmedetomidine
patients receive local anesthetic wound infiltration with 1µg/kg dexmedetomidine
bupivacaine
patients receive local anesthetic wound infiltration with bupivacaine 0.5 % diluted in 20 ml saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age range (18-60) years,
* weight (50- 90) kg
Exclusion Criteria
* significant cardiac disease
* respiratory disease
* renal disease
* hepatic disease
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Adel El sherif,MD
lecturer of anesthesia ,ICU and pain releif
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
fatma el sherif, MD
Role: PRINCIPAL_INVESTIGATOR
South Egypt Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Egypt Cancer instIitute
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
388
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.